Impact of time of initiation of once-monthly paliperidone palmitate in hospitalized Asian patients with acute exacerbation of schizophrenia: a post hoc analysis from the PREVAIL study

PURPOSE: To evaluate the differences in efficacy and safety outcomes in acute exacerbating schizophrenia patients between 2 subgroups (≤1 week and >1 week), differing in time interval from hospitalization to time of initiation of once-monthly paliperidone palmitate. PATIENTS AND METHODS: PREVAIL...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huafang, Li, Yan, Feng, Yu, Zhuo, Jianmin, Turkoz, Ibrahim, Mathews, Maju, Tan, Wilson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927347/
https://www.ncbi.nlm.nih.gov/pubmed/29731633
http://dx.doi.org/10.2147/NDT.S157399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927347/
https://www.ncbi.nlm.nih.gov/pubmed/29731633
http://dx.doi.org/10.2147/NDT.S157399

Ejemplares similares